GoKawiilFDA scientists resisted RFK Jr.-backed push to ease peptide drug access
FDA scientific staff largely opposed a policy that would have made it easier for Americans to obtain unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr., according to six people familiar with its development. Agency officials reportedly warned that career scientists had serious safety concerns and would not endorse a regulation declaring the peptides safe, and staff said they had limited input in drafting the policy.